| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/25/2009 | US20090162834 Molecular sequence of swine retrovirus and methods of use |
| 06/25/2009 | US20090162831 human parvovirus |
| 06/25/2009 | US20090162427 Vaccines using nucleic acid-lipid complexes |
| 06/25/2009 | US20090162422 Single-domain brain-targeting antibody fragments derived from LLAMA antibodies |
| 06/25/2009 | US20090162405 Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells |
| 06/25/2009 | US20090162404 Tumor vaccine |
| 06/25/2009 | US20090162403 Process for producing an allergen extract |
| 06/25/2009 | US20090162402 Immunizing compositions and methods of use |
| 06/25/2009 | US20090162401 Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development |
| 06/25/2009 | US20090162400 Compositions of influenza viral proteins and methods of use thereof |
| 06/25/2009 | US20090162399 Nef deleted human immunodeficiency virus for the restoration of T-lymphocyte signaling and activation for the treatment and prevention of human immunodeficiency virus infection |
| 06/25/2009 | US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| 06/25/2009 | US20090162397 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 06/25/2009 | US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/25/2009 | US20090162395 Vaccine for rsv and mpv |
| 06/25/2009 | US20090162394 Vaccine |
| 06/25/2009 | US20090162393 Vaccine composition and uses thereof |
| 06/25/2009 | US20090162392 Mutant forms of streptolysin o |
| 06/25/2009 | US20090162391 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | US20090162390 Molecular Scaffolds for HIV-1 Immunogens |
| 06/25/2009 | US20090162389 Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity |
| 06/25/2009 | US20090162388 epitope of salmonid alphaviruses capable of inducing a virus neutralizing immune response |
| 06/25/2009 | US20090162387 Preventive and therapeutic vaccine for alzheimer's disease |
| 06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
| 06/25/2009 | US20090162385 Compositions for and methods of enhancing the immune response to antigens |
| 06/25/2009 | US20090162384 Consensus/ancestral immunogens |
| 06/25/2009 | US20090162383 Method for designing vaccines against constantly mutating pathogens |
| 06/25/2009 | US20090162382 Optimized ca9 antibodies and methods of using the same |
| 06/25/2009 | US20090162381 Method for Treating Vascular Disorders |
| 06/25/2009 | US20090162380 Multispecific binding molecules comprising connecting peptides |
| 06/25/2009 | US20090162379 Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor |
| 06/25/2009 | US20090162378 Anti-human cytomegalovius antibodies |
| 06/25/2009 | US20090162377 Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform |
| 06/25/2009 | US20090162376 Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
| 06/25/2009 | US20090162375 Resistin antagonists and their use |
| 06/25/2009 | US20090162374 Specific removal of activated immune cells |
| 06/25/2009 | US20090162373 Materials and methods for treatment of hepatitis c |
| 06/25/2009 | US20090162372 Fibronectin ed-b antibodies, conjugates thereof, and methods of use |
| 06/25/2009 | US20090162371 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 06/25/2009 | US20090162370 Compositions and methods for conditioning a subject for hematopoietic cell transplantation |
| 06/25/2009 | US20090162369 Synthetic chimeric peptides |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162366 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/25/2009 | US20090162365 Novel siRNAS and methods of use thereof |
| 06/25/2009 | US20090162364 Apo-2 ligand |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162362 Alzheimer's disease treatment method |
| 06/25/2009 | US20090162361 Method for diagnosing pancreatic cancer |
| 06/25/2009 | US20090162360 Bivalent, bispecific antibodies |
| 06/25/2009 | US20090162359 Bivalent, bispecific antibodies |
| 06/25/2009 | US20090162358 Antigen binding proteins |
| 06/25/2009 | US20090162357 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 06/25/2009 | US20090162356 CRIg antagonists |
| 06/25/2009 | US20090162355 Treatment of tumors using specific anti-l1 antibody |
| 06/25/2009 | US20090162354 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 06/25/2009 | US20090162353 Compositions for the Prevention and Treatment of Smallpox |
| 06/25/2009 | US20090162352 Antibody formulation |
| 06/25/2009 | US20090162351 Transdiscal administration of inhibitors of p38 MAP kinase |
| 06/25/2009 | US20090162350 Novel composition and methods for the treatment of immune related disease |
| 06/25/2009 | US20090162349 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
| 06/25/2009 | US20090162348 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162346 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of SEQ ID NOS:526, 92-525, and 527-584 |
| 06/25/2009 | US20090162345 Materials and Methods for Reversing Type-1 Diabetes |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162328 In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation |
| 06/25/2009 | US20090162317 Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same |
| 06/25/2009 | US20090162315 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/25/2009 | US20090162279 Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm |
| 06/25/2009 | DE102007062962A1 Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg) New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg) |
| 06/25/2009 | CA2710061A1 Rhoc-based immunotherapy |
| 06/25/2009 | CA2709135A1 Treatment of interstitial cystitis |
| 06/25/2009 | CA2708854A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | CA2708221A1 Antibodies against influenza virus and methods of use thereof |
| 06/25/2009 | CA2708167A1 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | CA2707637A1 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 06/25/2009 | CA2707309A1 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| 06/25/2009 | CA2707304A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 06/25/2009 | CA2707235A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/25/2009 | CA2706617A1 Adjuvanted glucans |
| 06/24/2009 | EP2072617A1 Method for producing dendritic cells |
| 06/24/2009 | EP2072059A1 Use of bispecific antibodies to regulate immune responses |
| 06/24/2009 | EP2072058A1 Modified influenza virus |
| 06/24/2009 | EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 06/24/2009 | EP2072040A1 Therapeutic use of nucleic acid micropheres |
| 06/24/2009 | EP1801119B1 Interleukin-15 antagonist peptide |
| 06/24/2009 | EP1706145B1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 06/24/2009 | EP1654286B1 Humanized anti-cd4 antibody with immunosuppressive properties |
| 06/24/2009 | EP1575522B1 Methods for treating pain by administering an antagonist antibody against the nerve growth factor and an opioid analgesic and compositions containing the same |
| 06/24/2009 | EP1539231B1 Iscom preparation and use thereof |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it |
| 06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
| 06/24/2009 | EP0935664B1 New systems for regulating genetic expression |
| 06/24/2009 | CN101466406A Use of alpha-toxin for treating and preventing staphylococcus infections |
| 06/24/2009 | CN101466405A Anti KU70 internalizing antibodies |
| 06/24/2009 | CN101466404A Lyophilized formulations of anti-EGFR antibodies |
| 06/24/2009 | CN101466403A Method for delivering a human chorionic gonadotropin (hCG) vaccine for long-acting antibody production |